Please use this identifier to cite or link to this item:
http://hdl.handle.net/11452/27383
Title: | Serum choline levels in patients with stable angina and acute coronary syndromes: Relation to the severity of coronary artery disease |
Authors: | Uludağ Üniversitesi/Tıp Fakültesi/Kardiyoloji Anabilim Dalı. Uludağ Üniversitesi/Tıp Fakültesi/Tıbbi Farmakoloji Anabilim Dalı. 0000-0002-8974-8837 Şentürk, Tunay Tütüncü, Ahmet Özdemir, Bülent Özdabakoğlu, Osman Aydın, Sami Baran, İbrahim Güllülü, Sümeyye Savcı, Vahide Aydınlar, Ali AAI-6632-2021 C-1517-2017 8342098300 7004229025 7004168959 25221805700 7005387015 35572557400 57204660708 6603687024 6603131517 |
Keywords: | Acute coronary syndrome Choline Coronary artery disease Stable angina pectoris Whole-blood choline Phospholipase-D Plaque vulnerability Atherosclerosis Macrophages Biomarkers Activation Mechanisms Ischemia Cardiovascular system & cardiology |
Issue Date: | Dec-2010 |
Publisher: | Lippincott Williams & Wilkins |
Citation: | Şentürk, T. vd. (2010). "Serum choline levels in patients with stable angina and acute coronary syndromes: Relation to the severity of coronary artery disease". Coronary Artery Disease, 21(8), 466-471. |
Abstract: | Objective We sought to investigate whether serum choline levels are increased across the spectrum of coronary artery disease (CAD) manifestations and correlate with the severity of coronary stenosis. Methods A total of 36 patients with acute coronary syndrome (ACS) [22 patients with non-ST-segment elevation ACS and 14 patients with ST-segment elevation acute myocardial infarction (STEMI)], 22 patients with stable angina pectoris (SAP), and 18 controls were recruited for the study. In ACS patients, serum choline levels were measured on admission, and at 24 and 48 h thereafter, using high-performance liquid chromatography. The severity of CAD was assessed using the Gensini score. Results Serum choline levels on admission were significantly higher in the entire group of patients with ACS than in controls. The highest level of choline was observed in the STEMI group, followed by the SAP, and the non-ST-segment elevation ACS groups. Serum choline levels decreased gradually in patients with STEMI over the 48-h period. Serum choline levels on admission, and at 24 or 48 h thereafter, did not correlate with the presence of CAD neither in patients with ACS (P = 0.78, 0.98 and 0.98, respectively) nor in those with SAP (P = 0.92). Conclusion Our results suggest that serum choline levels are increased in ACS patients. However, there was no clear correlation between levels of choline and the severity and extent of CAD in this patient group. Coron Artery Dis 21:466-471 |
URI: | https://doi.org/10.1097/MCA.0b013e32833bdf39 https://journals.lww.com/coronary-artery/Fulltext/2010/12000/Serum_choline_levels_in_patients_with_stable.5.aspx http://hdl.handle.net/11452/27383 |
ISSN: | 0954-6928 |
Appears in Collections: | Scopus Web of Science |
Files in This Item:
There are no files associated with this item.
Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.